* ContraFect Corp CFRX.OQ CFRX.O is expected to show no
change
in quarterly revenue when it reports results on November 14
(estimated).
*
* Refinitiv's mean analyst estimate for ContraFect Corp is
for a
loss of 23 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for ContraFect
Corp
is $3, above its last closing price of $0.14.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.38 -0.37 -0.46 Missed -23.5
Mar. 31 2022 -0.32 -0.31 -0.51 Missed -63.5
Dec. 31 2021 -0.25 -0.27 -0.11 Beat 60
Sep. 30 2021 -0.29 -0.28 -0.13 Beat 54
Jun. -0.30 -0.28 -0.14 Beat 50
30 2021
Mar. 31 2021 -0.22 -0.22 -0.18 Beat 18.2
Dec. 31 2020 -0.27 -0.31 -0.23 Beat 24.8
Sep. 30 2020 -0.34 -0.38 0.12 Beat 131.4
This summary was machine generated November 11 at 16:09 GMT.
All figures in US dollars unless otherwise stated